StockClub

ASND

ASNDAscendis Pharma A/S$ --
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
245M EUR
YoY +41.0%
Operating Income
10M EUR
YoY +2459.6%
Net Income
-33M EUR
YoY +13.6%
EPS
-0.54EUR
YoY +15.6%

Revenue

EUR717.8M
FY2024 Q1EUR95.9M
EUR95.9M
Q1
FY2024 Q2EUR131.9M
EUR131.9M
Q2
FY2024 Q3EUR189.7M
EUR189.7M
Q3
FY2024 Q4EUR363.6M
EUR363.6M
Q4
FY2025 Q1EUR101M
EUR101M
Q1
FY2025 Q2EUR259M
EUR259M
Q2
FY2025 Q3EUR472.6M
EUR472.6M
Q3
FY2025 Q4EUR717.8M
EUR717.8M
Q4
Actual
+EUR354.2M (+97.4%)

Net Income

EUR-227.7M
FY2024 Q1EUR-131M
EUR-131M
Q1
FY2024 Q2EUR-240.4M
EUR-240.4M
Q2
FY2024 Q3EUR-339.6M
EUR-339.6M
Q3
FY2024 Q4EUR-378.1M
EUR-378.1M
Q4
FY2025 Q1EUR-94.6M
EUR-94.6M
Q1
FY2025 Q2EUR-133.5M
EUR-133.5M
Q2
FY2025 Q3EUR-194.5M
EUR-194.5M
Q3
FY2025 Q4EUR-227.7M
EUR-227.7M
Q4
Actual
+EUR150.4M (+39.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:EUR7M
Est:EUR8.9M
FY2020MISS
EUR7M
FY2021BEAT
Actual:EUR7.8M
Est:EUR6.6M
FY2021BEAT
EUR7.8M
FY2022BEAT
Actual:EUR51.2M
Est:EUR45.9M
FY2022BEAT
EUR51.2M
FY2023MISS
Actual:EUR266.7M
Est:EUR296M
FY2023MISS
EUR266.7M
FY2024BEAT
Actual:EUR363.6M
Est:EUR311.1M
FY2024BEAT
EUR363.6M
FY2025MISS
Actual:EUR691.7M
Est:EUR708.3M
FY2025MISS
EUR691.7M

Analyst Estimates